The impact of policy on availability and price of low‐price medicines in public healthcare institutions: A retrospective survey in Nanjing, China

Yulei Zhu, Yuqin Ren, Hui Wang, Wenqing Fang, Xinglu Xu, Ying Wang, Huizhen Dai and Xin Li

International Journal of Health Planning and Management, 2022, vol. 37, issue 2, 1118-1130

Abstract: In an effort to promote rational drug pricing and relieve the pressure of drug shortages, the Chinese government implemented a low‐price medicine (LPM) policy in July 2014, and abolished price regulations for most medications in June 2015. This study examines trends in the availability and pricing of LPMs since policy implementation. Data on price and availability of 752 LPMs during 2013–2017 were obtained from the Jiangsu Institute of Medicine Information. Availability was defined as the proportion of facilities in which a medicine was in inventory during each survey period. A price index was constructed based on purchasing prices in 40 public healthcare facilities, using a standard method developed by the International Labour Organization. Mean availability fluctuated slightly but held at low levels (

Date: 2022
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://doi.org/10.1002/hpm.3395

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:bla:ijhplm:v:37:y:2022:i:2:p:1118-1130

Ordering information: This journal article can be ordered from
http://www.blackwell ... bs.asp?ref=0749-6753

Access Statistics for this article

International Journal of Health Planning and Management is currently edited by Calum Paton

More articles in International Journal of Health Planning and Management from Wiley Blackwell
Bibliographic data for series maintained by Wiley Content Delivery ().